B
Bicara Therapeutics Inc. (BCAX)
NGM – Real Time Price. Currency in USD
26.87
+0.53 (2.01%)
At close: Jun 26, 2026, 4:00 PM EDT
26.87
-0.00 (-0.00%)
After-hours: Jun 26, 2026, 4:35 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
26.87
+0.53 (2.01%)
At close: Jun 26, 2026, 4:00 PM EDT
26.87
-0.00 (-0.00%)
After-hours: Jun 26, 2026, 4:35 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $323.5M significantly exceed its total debt $1.4M, ensuring strong financial flexibility
Total current assets $544.9M exceed Total current liabilities $39.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$37.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 13.85 | 6.05 | 10 | |
| Quick ratio | 13.85 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -10K | -19K | -56K | -105K | -130K |
| Operating Income | -38M | -40M | -82M | -156M | -174M |
| Net Income | -38M | -52M | -68M | -138M | -157M |
| EBITDA | -38M | -40M | -82M | -155M | -174M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -63.96 | 1.0 |
| Next quarter | N/A | -26.47 | 1.0 |
| Current year | N/A | -38.35 | 1.0 |
| Next year | N/A | -6.17 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -50.34 | -36.75 | -55.72 | 3.3 |
| Y/Y | 999 | -52.55 | -36.75 | -33.66 | 3.3 |
| 3y average | 999 | -56.99 | N/A | -49.41 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 2.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |